Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy

BACKGROUND: The aim of the study was to explore the prognostic impact of different abnormal blood tests and the tumor marker CA 15-3 as well as established parameters such as disease extent and receptor status in patients with bone metastases from breast cancer who received palliative radiotherapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Dalhaug, Astrid, Haukland, Ellinor, Mannsaker, Bard, Pawinski, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289136/
https://www.ncbi.nlm.nih.gov/pubmed/28179964
http://dx.doi.org/10.14740/jocmr2653w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289136/
https://www.ncbi.nlm.nih.gov/pubmed/28179964
http://dx.doi.org/10.14740/jocmr2653w

Ejemplares similares